|
|
|
|
|
Detail |
| hsa-miR-203 |
|
Unspecified |
Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. |
2006 |
|
|
|
|
|
|
| hsa-miR-203 |
|
Causal |
MicroRNAs: novel regulators involved in the pathogenesis of Psoriasis? |
2007 |
|
|
|
|
|
|
| hsa-miR-203 |
|
Unspecified |
Micro-RNA profiling in kidney and bladder cancers. |
2007 |
|
|
|
|
|
|
| hsa-miR-203 |
|
Unspecified |
MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma. |
2008 |
|
|
|
|
|
|
| hsa-miR-203 |
|
Unspecified |
MicroRNA gene expression deregulation in human breast cancer. |
2005 |
|
|
|
|
|
|
| hsa-miR-203 |
|
Unspecified |
MicroRNA expression alterations are linked to tumorigenesis and non-neoplastic processes in pancreatic ductal adenocarcinoma. |
2007 |
|
|
|
|
|
|
| hsa-miR-203 |
|
Causal |
A skin microRNA promotes differentiation by repressing 'stemness'. |
2008 |
|
|
|
|
|
|
| hsa-miR-203 |
|
Unspecified |
Exploration of tumor-suppressive microRNAs silenced by DNA hypermethylation in oral cancer. |
2008 |
|
|
|
|
|
|
| hsa-miR-203 |
|
Unspecified |
Effect of miRNA-10b in regulating cellular steatosis level by targeting PPAR-alpha expression, a novel mechanism for the pathogenesis of NAFLD |
2009 |
|
|
|
|
|
|
| hsa-miR-203 |
|
Unspecified |
MicroRNA expression in squamous cell carcinoma and adenocarcinoma of the esophagus: associations with survival |
2009 |
|
|
|
|
|
|
| hsa-miR-203 |
|
Unspecified |
Characterization of global microRNA expression reveals oncogenic potential of miR-145 in metastatic colorectal cancer |
2009 |
|
|
|
|
|
|
| hsa-miR-203 |
|
Causal |
miR-124 and miR-203 are epigenetically silenced tumor-suppressive microRNAs in hepatocellular carcinoma |
2009 |
|
|
|
|
|
|
| hsa-miR-203 |
|
Unspecified |
MicroRNA expression profiles of esophageal cancer. |
2008 |
|
|
|
|
|
|
| hsa-miR-203 |
|
Unspecified |
Differential expression of microRNA species in human uterine leiomyoma versus normal myometrium. |
2008 |
|
|
|
|
|
|
| hsa-miR-203 |
|
Causal |
Genetic and epigenetic silencing of microRNA-203 enhances ABL1 and BCR-ABL1 oncogene expression. |
2008 |
|
|
|
|
|
|
| hsa-miR-203 |
|
Causal |
Genetic and epigenetic silencing of microRNA-203 enhances ABL1 and BCR-ABL1 oncogene expression. |
2008 |
|
|
|
|
|
|
| hsa-miR-203 |
|
Unspecified |
MicroRNAs are differentially expressed in ulcerative colitis and alter expression of macrophage inflammatory peptide-2 alpha. |
2008 |
|
|
|
|
|
|
| hsa-miR-203 |
|
Unspecified |
A miRNA signature of prion induced neurodegeneration. |
2008 |
|
|
|
|
|
|
| hsa-miR-203 |
|
Unspecified |
CDKN2A, NF2, and JUN are dysregulated among other genes by miRNAs in malignant mesothelioma -A miRNA microarray analysis. |
2009 |
|
|
|
|
|
|
| hsa-miR-203 |
|
Unspecified |
The expression profile of microRNAs in a model of
7,12-dimethyl-benz[a]anthrance-induced oral carcinogenesis in Syrian hamster. |
2009 |
|
|
|
|
|
|
| hsa-miR-203 |
|
Unspecified |
Elevated expression of microRNAs 155, 203, 210 and 222 in pancreatic tumours associates with poorer survival. |
2009 |
|
|
|
|
|
|
| hsa-miR-203 |
|
Unspecified |
Elevated expression of microRNAs 155, 203, 210 and 222 in pancreatic tumours associates with poorer survival. |
2009 |
|
|
|
|
|
|